INCREASED RISK OF GRAFT LOSS IN MYCOPHENOLATE MOFETIL (MMF) AND TACROLIMUS (TACRO)-TREATED RENAL TRANSPLANT RECIPIENTS (RTRʼS) WITH ACUTE REJECTION